Amundi’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Amundi's OGN Position: Q2 2026 in Review
Amundi reduced its Organon & Co (OGN) stake by 9.8% in Q2 2026, selling an estimated $94.7K and leaving 73,025 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #1376.
Amundi first reported a position in OGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $112M in Q1 2023. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Amundi held 73,025 shares of Organon & Co worth $989K as of Q2 2026.
- Amundi sold 7,919 Organon & Co shares in Q2 2026, an estimated $94.7K.
- Organon & Co made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1376 holding.
- Amundi first reported a position in Organon & Co in Q3 2021 and has held it in 20 quarters since.
- Amundi's Organon & Co position peaked at $112M in Q1 2023.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.